![Karl Whitney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Whitney
Consigliere Generale presso
PASSAGE BIO, INC.
Profilo
Karl Whitney is Senior Vice President-Global Regulatory Affairs at Passage Bio, Inc. since 2024.
Dr. Whitney is Co-President at International Foxp1 Foundation since 2021.
Formerly, Dr. Whitney was Vice President & Head-Regulatory Affairs at Precision BioSciences, Inc. from 2020 to 2024.
Dr. Whitney was Principal at Rho, Inc. Education includes undergraduate studies at Yale University and a doctorate from Duke University.
Posizioni attive di Karl Whitney
| Società | Posizione | Inizio |
|---|---|---|
| PASSAGE BIO, INC. | Consigliere Generale | 01/02/2024 |
Precedenti posizioni note di Karl Whitney
| Società | Posizione | Fine |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Consigliere Generale | 01/01/2024 |
Rho, Inc.
 Rho, Inc. Miscellaneous Commercial ServicesCommercial Services Provides collection processing and management of clinical research | Corporate Officer/Principal | - |
Formazione di Karl Whitney
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rho, Inc.
Rho, Inc. Miscellaneous Commercial ServicesCommercial Services Provides collection processing and management of clinical research | Commercial Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
